LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged arthrex ptab · clear

PTAB

No Arthrex Relief for Failed PTAB Petitioners

CAFC Holds Petitioner to PTAB Choice While we await the en banc determination in Arthrex/Polaris , there have been a number of recent remands back to the PTAB (i.e., where the Appointments Clause issue was first raised in the opening appellate brief).…

January 30, 2020·PTAB·2 min read
PTAB

En Banc CAFC to Debate PTAB Appointments Clause Issue

Gov’t Questions Fundamental Aspects of Court Decision As promised, the government has now sought en banc rehearing in Arthrex . In its petition, the government revisits the bases for the Court’s October decision and encourages the Court to also…

December 18, 2019·PTAB·2 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data